Health Data Global Hybrid Summit 2024

Keynote Addresses

Our distinguished keynote speakers at the Health Data Forum Global Hybrid Summit 2024 delved into the multifaceted role of Real-World Evidence (RWE) in transforming healthcare. From groundbreaking innovations to shaping public policy and regulatory frameworks, their diverse expertise sheds light on new possibilities for harnessing health data to drive meaningful change and improve outcomes.

2024 Agenda at a Glance

Day 0 (14 November)

Pre-Summit Symposium:

The Impact of Real-World Evidence (RWE) in Clinical Pathways

Location: NOVA School of Business and Economics & NOVA Medical School

• Morning (Portuguese session):
  Opening Keynote: Maria de Belém Roseira, former Minister of Healthcare
  Roundtable: Impact of RWE on Clinical Pathways, moderated by Filipe Costa (Nova SBE)
  Workshop: Design of Clinical Pathways – Group Work and Debriefing

• Afternoon (English session):
  Opening Address: Stefan Buttigieg, Vice President, EUPHA Digital Health Section
  Panel Discussion: Healthcare Transformation with contributions from Fatih Mehmet Gul (Jeddah), Manuel Bosch Arcos (Ribera Salud), Maria João Jacinto (Patient Innovation), Rhidian Hurle (CCIO NHS Wales)
  Closing Keynote: Shirley Wang (Harvard Medical School) on New Approaches to RWE in Clinical Pathways
  Networking Drinks: Connect with global health data leaders.
  

Our pre-summit Symposium is powered by UpHill Health

Day 1 (15 November)

Real-World Evidence and Public Health Data

Location: Paula Rego Museum, Cascais

• Morning Session
  Keynotes:
• Shirley Wang (Harvard Medical School)
• Elisa Tarazona Ginés (CEO, Ribera Salud) on population health and value-based care
• Late Morning Session 2: The Burden of Disease in Real-World Settings, featuring key insights from Juan Ventura (Cancer Patients Europe), Fatih Mehmet Gul (CEO at The View Hospital), Fredrik Nyberg (Gothenburg University), and Bochen Cao (WHO), chaired by Gustavo Tato Borges (Public Health Specialist, President of the National Association of Public Health Medicine) and moderated by Mariana Pais (Data Science Director MTG Research & Development Lab).
  World Café Discussion: Engage with speakers in small-group discussions on RWE and disease burden
• Afternoon Sessions
  Track 1 (Technical): Best Practices in RWE Data Governance Pantelis Natsiavas (Institute of Applied Biosciences, Greece), Niels Bolding (Health-RI, Netherlands), Paola Quattroni (EACTS, European Association for Cardio-Thoracic Surgery, UK) and Hugo Pedrosa (IQVIA, Portugal), who will be moderating.
  Track 2 (Non-Technical): RWE's Role in Public Engagement and Research Alexandra Eva Stege (Biobank Charité, Germany) Chantal Steegers, Health-RI, Netherlands, Inês Sousa (Fraunhofer Portugal), Maria Dutarte (EUPATI), and Pedro Guimarães Cunha (Alto Ave Local Health Authority, Portugal) who will be moderating.
• Session 4: The Role of RWE in Shaping Public Health Policy - Chaired by Prof. Rhidian Hurle, CCIO NHS Wales, the session will feature insights from Bárbara Carvalho (Cascais City Council), Daniel Morales (European Medicines Agency), and Dr Doreen Tembo (Health Data Research UK, online), offering diverse perspectives on the integration of RWE into healthcare systems for more effective policymaking.
• Closing Reflections & Networking Dinner: Led by Conceição Calhau (NOVA Medical School), with a dinner with honourable Teresa Almeida, President of the Regional Coordination and Development Commission of Lisbon and Tagus Valley.

Day 2 (16 November)

Health Technology Assessment (HTA)

Location: Paula Rego Museum, Cascais

• Morning Session
• Keynotes: Saleem Sayani (Aga Khan University) and Pedro Ramos (Madeira Healthcare Secretary)
• Session 5: : Foundational Steps for integrating RWE in Public Health – featuring Nawin Sona Natesan, Secretary to Government, Public Health Department, Govt. of Maharashtra, Ismail Gogenur, Medical Researcher, Zealand University Hospital and University of Copenhagen moderated by Bruna Gouveia (Madeira Region Healthcare) and Tiago Taveira Gomes, (Founder & CEO Sigil Scientific Enterprises).
• Late Morning | Keynotes on the Future of HTA Assessment Elena Petelos (HTAi) and Rui Santos Ivo (President of Infarmed).
• Afternoon Sessions
  Session 6: Innovations in Chronic Patient Management and Longevity – with Gonçalo Sarmento e Costa (CEO at ULS Entre Douro e Vouga) and Ana Clara Mendonça e Silva (Regional Director for Public Policies and Longevity, Madeira)
  Session 7: AI in Action: Strategy Transforms Patient Experience – moderated by Maria João Lupi (DPO, Lisbon West Health Authority)
• Closing Session: Reflections on Future Directions in Health Data
  Keynote: Eric Sutherland (OECD) Chaired by George Mathew (Chair of Advisory Board Health Data Forum)

The Health Data Forum 2024 Venue

Our event partners and sponsors